IDEAYA Biosciences Inc. (NASDAQ: IDYA) will announce topline results from its Phase 2/3 OptimUM-02 trial on April 13, 2026, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE